Skip to content

PAVOBUR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PAVOBUR

BE 0458.142.282
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€316,904
2024 · €284,366+€32,539
Equity
€355,458
2024 · €353,554+€1,904
Cash
€180,550
2024 · €338,628-€158,078
Balance sheet total
€943,141
2024 · €845,357+€97,783

Largest movements

2024 to 2025
Assets
  • Cash -€158,078

    down €158,078 (-46.7%), from €338,628 to €180,550

    mainly Contributions, distributions and other (-€315,000) and Current investments (-€140,000)

  • Current investments +€140,000

    new in 2025: €140,000

  • Receivables within one year +€86,784

    up €86,784 (+37.7%), from €230,326 to €317,109

    of which Trade receivables: +€68,149

  • Stocks and contracts +€24,227

    up €24,227 (+10.4%), from €233,603 to €257,830

Equity and liabilities
  • Trade debts +€75,258

    up €75,258 (+58.2%), from €129,328 to €204,586

  • Other debts +€12,517

    up €12,517 (+3.7%), from €336,805 to €349,322

Income statement
  • Gross operating margin +€43,412

    up €43,412 (+9.2%), from €473,745 to €517,156

  • Staff costs +€12,841

    up €12,841 (+7.3%), from €176,473 to €189,314

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €284,366
Gross operating margin +€43,412
Staff costs -€12,841
Depreciation -€599
Other operating charges +€616
Financial income +€1,050
Financial charges -€777
Taxes +€1,678
Result 2025 €316,904
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€314,268
Investment -€157,346
Financing -€315,000
Cash 2024 €338,628
Net result for the year +€316,904
Depreciation +€12,511
Stocks and contracts -€24,227
Receivables within one year -€86,784
Smaller working-capital items -€724
Trade debts +€75,258
Tax, wage and social debts +€8,812
Other debts +€12,517
Investment in fixed assets (net) -€17,346
Current investments -€140,000
Contributions, distributions and other -€315,000
Cash 2025 €180,550
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €845,357 €943,141 +€97,783 +11.6%
Fixed assets 21/28 €35,792 €40,627 +€4,835 +13.5%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €35,792 €40,627 +€4,835 +13.5%
Plant, machinery and equipment 23 €252 €1,762 +€1,510 +599%
Furniture and vehicles 24 €5,411 €1,894 -€3,516 -65.0%
Other tangible fixed assets 26 €30,129 €36,970 +€6,841 +22.7%
Current assets 29/58 €809,565 €902,514 +€92,949 +11.5%
Stocks and contracts in progress 3 €233,603 €257,830 +€24,227 +10.4%
Stocks 30/36 €233,603 €257,830 +€24,227 +10.4%
Amounts receivable within one year 40/41 €230,326 €317,109 +€86,784 +37.7%
Trade receivables 40 €172,524 €240,673 +€68,149 +39.5%
Other amounts receivable 41 €57,802 €76,436 +€18,635 +32.2%
Current investments 50/53 - €140,000 +€140,000
Cash at bank and in hand 54/58 €338,628 €180,550 -€158,078 -46.7%
Deferred charges and accrued income 490/1 €7,008 €7,024 +€16 +0.2%
Total equity and liabilities 10/49 €845,357 €943,141 +€97,783 +11.6%
Equity 10/15 €353,554 €355,458 +€1,904 +0.5%
Contributions 10/11 €61,500 €61,500 = 0.0%
Capital 10 €61,500 €61,500 = 0.0%
Issued capital 100 €61,500 €61,500 = 0.0%
Reserves 13 €292,054 €293,958 +€1,904 +0.7%
Non-distributable reserves 130/1 €6,150 €6,150 = 0.0%
Legal reserve 130 €6,150 €6,150 = 0.0%
Tax-exempt reserves 132 €11,220 €11,220 = 0.0%
Distributable reserves 133 €274,684 €276,588 +€1,904 +0.7%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €491,803 €587,682 +€95,879 +19.5%
Amounts payable within one year 42/48 €489,396 €585,983 +€96,587 +19.7%
Trade debts 44 €129,328 €204,586 +€75,258 +58.2%
Suppliers 440/4 €129,328 €204,586 +€75,258 +58.2%
Advances received on contracts in progress 46 €0 - =
Taxes, remuneration and social security 45 €23,263 €32,075 +€8,812 +37.9%
Taxes 450/3 €3,993 €0 -€3,993 -100%
Remuneration and social security 454/9 €19,270 €32,075 +€12,805 +66.5%
Other amounts payable 47/48 €336,805 €349,322 +€12,517 +3.7%
Accrued charges and deferred income 492/3 €2,407 €1,699 -€708 -29.4%
Remuneration, social security and pensions 62 €176,473 €189,314 +€12,841 +7.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,912 €12,511 +€599 +5.0%
Other operating charges 640/8 €1,381 €765 -€616 -44.6%
Gross operating margin 9900 €473,745 €517,156 +€43,412 +9.2%
Operating profit (loss) 9901 €283,978 €314,566 +€30,588 +10.8%
Financial income 75/76B €3,167 €4,216 +€1,050 +33.1%
Recurring financial income 75 €3,167 €4,216 +€1,050 +33.1%
Financial charges 65/66B €873 €1,650 +€777 +88.9%
Recurring financial charges 65 €873 €1,650 +€777 +88.9%
Profit (loss) for the period before taxes 9903 €286,271 €317,132 +€30,861 +10.8%
Income taxes 67/77 €1,906 €228 -€1,678 -88.0%
Profit (loss) for the period 9904 €284,366 €316,904 +€32,539 +11.4%
Profit (loss) for the period to be appropriated 9905 €284,366 €316,904 +€32,539 +11.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.